GEN News Highlights: Jan 26, 2012

GEN Readers Expect Justices to Side with Mayo in Diagnostics Case Against Prometheus

(Page 1 of 1)

    Prometheus v. Mayo will be an open-and-shut U.S. Supreme Court case for Mayo Collaborative Services, judging by GEN's poll on the outcome of this lawsuit.Some 70% of respondents predict that the high court will rule against Prometheus Laboratories, overturning the decision by the Court of Appeals for the Federal Circuit last December. While 10% of respondents were undecided, 20% believe that Prometheus will win out.

    The key question wrought by the patent litigation is: When does a claim involving diagnostic and treatment-related chemical observations, among examples of natural phenomena, meet the threshold for patent eligibility? The case is being closely watched by molecular diagnostics companies seeking direction about what intellectual property they can and cannot patent.


Related content

Subscription center

GEN MAGAZINE

Genetic Engineering & Biotechnology News (GEN) has retained its position as the most widely read biotechnology publication around the globe since its launch in 1981. Published 21 times a year and with additional exclusive editorial content online, GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization.

Subscribe

e-NEWSLETTERS

Add GEN to your Inbox! Subscribe today to our complimentary e-newsletters and stay abreast of the latest biotech news and trends. Click the magnifying glass icon next to a newsletter title to view a sample.

 

All fields are required

Email
  Confirm Email
  First Name
  Last Name
  Organization
  E-Alert Format
 
 
  Sign Up

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

GENpoll

FDA Performance

How much progress do you think FDA has made in reviewing drugs and bringing them to market faster?

Suggest a Poll